Antioxidant and signal modulation properties of plant polyphenols in controlling vascular inflammation

European Journal of Pharmacology

Volumn 658, Issue 2-3, 2011, Pages 248-256

  Kostyuk, Vladimir A ^a,b   Potapovich, Alla I ^a,b   Suhan, Tatyana O ^b   De Luca, Chiara ^a   Korkina, Liudmila G ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b BELARUSIAN STATE UNIVERSITY   (Belarus)

Author keywords

Atherosclerosis; Cytokines; HUVEC; Inflammation; Oxidized LDL; Polyphenols

Indexed keywords

LOW DENSITY LIPOPROTEIN; MESSENGER RNA; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; POLYPHENOL DERIVATIVE; QUERCETIN; RESVERATROL; SUPEROXIDE;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; LEUKOCYTE ADHERENCE; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PHYTOCHEMISTRY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; VASCULITIS;

ANTIOXIDANTS; BLOOD VESSELS; CELL ADHESION; CELL LINE; CELL PROLIFERATION; CHEMOTAXIS, LEUKOCYTE; ENDOTHELIAL CELLS; FLAVONOIDS; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; LIPOPROTEINS, LDL; NITRIC OXIDE; NITRITES; OXIDATION-REDUCTION; PEROXIDASE; PHENOLS; PLANTS; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 79953773488     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.02.022     Document Type: Article

References (54)

1. Anderson, J.W., Hanna, T.J., 1999. Impact of nondigestible carbohydrates on serum lipoproteins and risk for cardiovascular disease. J. Nutr. 129, 1457S-1466S.
2. Baldus, S., Eiserich, J.P., Brennan, M.-L., Jackson, R.M., Alexander, C.B., Freeman, B.A., 2002. Spatial mapping of pulmonary and vascular nitrotyrosine reveals the pivotal role of myeloperoxidase as a catalyst for tyrosine nitration in inflammatory diseases. Free Radic. Biol. Med. 33, 1010-1019.
3. Beckman, J.S., Beckman, T.W., Chen, J., Marshall, P.A., Freeman, B.A., 1990. Apparent hydroxyl radical production by peroxynitrite, implications for endothelial injury from nitric oxideand superoxide. Proc. Natl. Acad. Sci. U.S.A. 87, 1620-1624.
4. Berliner, J.A., Heinecke, J.W., 1996. The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 20, 707-727.
5. Blair, A., Shaul, P.W., Yuhanna, I.S., Conrad, P.A., Smart, E.J., 1999. Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation. J. Biol. Chem. 274, 32512-32519.
6. Carew, T.E., Schwenke, D.C., Steinberg, D., 1987. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect, evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc. Natl. Acad. Sci. U.S.A. 84, 7725-7729.
7. Carluccio, M.A., Siculella, L., Ancora, M.A., Massaro, M., Scoditti, E., Storelli, C., Visioli, F., Distante, A., De Caterina, R., 2003. Olive oil and red wine antioxidant polyphenols inhibit endothelial activation, antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler. Thromb. Vasc. Biol. 23, 622-629.
8. Carluccio, M.A., Ancora, M.A., Massaro, M., Carluccio, M., Scoditti, E., Distante, A., Storelli, C., De Caterina, R., 2007. Homocysteine induces VCAM-1 gene expression through NF-kappaB and NAD(P)H oxidase activation, protective role of Mediterranean diet polyphenolic antioxidants. Am. J. Physiol. Heart Circ. Physiol. 293, H2344-H2354.
9. Cheng, J.C., Fang, J.G., Chen, W.F., Zhou, B., Yang, L., Liu, Z.L., 2006. Structure-activity relationship studies of resveratrol and its analogues by the reaction kinetics of low density lipoprotein peroxidation. Bioorg. Chem. 34, 142-157.
10. Chisolm, G.M., 1991. Antioxidants and atherosclerosis, a current assessment. Clin. Cardiol. 14, I25-I30.
11. Chisolm, G.M., Steinberg, D., 2000. The oxidative modification hypothesis of atherogenesis, an overview. Free Radic. Biol. Med. 28, 1815-1826.
12. Choi, J.S., Choi, Y.J., Shin, S.Y., Li, J., Kang, S.W., Bae, J.Y., Kim, D.S., Ji, G.E., Kang, J.S., Kang, Y.H., 2008. Dietary flavonoids differentially reduce oxidized LDL-induced apoptosis in human endothelial cells: role of MAPK- and JAK/STAT-signaling. J. Nutr. 138, 983-990. (Pubitemid 351769118)
13. Cybulsky, M.I., Gimbrone Jr., M.A., 1991. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251, 788-791.
14. Cybulsky, M.I., Iiyama, K., Li, H., Zhu, S., Chen, M., Iiyama, M., Davis, V., Gutierrez-Ramos, J.C., Connelly, P.W., Milstone, D.S., 2001. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Invest. 107, 1255-1262.
15. Daugherty, A., Dunn, J.L., Rateri, D.L., Heinecke, J.W., 1994. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94, 437-444.
16. De Caterina, R., Libby, P., Peng, H.B., Thannickal, V.J., Rajavashisth, T.B., Gimbrone Jr., M.A., Shin, W.S., Liao, J.K., 1995. Nitric oxide decreased cytokine-induced endothelial activation, nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96, 60-68.
17. Esterbauer, H., Puhl, H., Dieber-Rotheneder, M., Waeg, G., Rabl, H., 1991. Effect of antioxidants on oxidative modification of LDL. 1991. Ann. Med. 23, 573-581.
18. Gey, K.F., Puska, P., Jordan, P., Moser, U.K., 1991. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am. J. Clin. Nutr. 53, 326S-334S.
19. Heinecke, J.W., Baker, L., Rosen, H., Chait, A., 1986. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J. Clin. Invest. 77, 757-761.
20. Hessler, J.R., Morel, D.W., Lewis, L.J., Chisolm, G.M., 1983. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis 3, 215-222. (Pubitemid 13099583)
21. Hiramatsu, K., Rosen, H., Heinecke, J.W., Wolfbauer, G., Chait, A., 1987. Superoxides initiate oxidation of low density lipoprotein by monocytes. Arteriosclerosis 7, 55-60. (Pubitemid 17014542)
22. Hung, L.M., Su, M.J., Chu, W.K., Chiao, C.W., Chan, W.F., Chen, J.K., 2002. The protective effect of resveratrols on ischaemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy. Br. J. Pharmacol. 135, 1627-1633.
23. Hwang, M.K., Song, N.R., Kang, N.J., Lee, K.W., Lee, H.J., 2009. Activation of phosphatidylinositol 3-kinase is required for tumor necrosis factor-alpha-induced upregulation of matrix metalloproteinase-9: its direct inhibition by quercetin. Int. J. Biochem. Cell Biol. 41, 1592-1600.
24. Jeong, Y.J., Choi, Y.J., Kwon, H.M., Kang, S.W., Park, H.S., Lee, M., Kang, Y.H., 2005. Differential inhibition of oxidized LDL-induced apoptosis in human endothelial cells treated with different flavonoids. Br. J. Nutr. 93, 581-591.
25. Jeong, Y.J., Choi, Y.J., Choi, J.S., Kwon, H.M., Kang, S.W., Bae, J.Y., Lee, S.S., Kang, J.S., Han, S.J., Kang, Y.H., 2007. Attenuation of monocyte adhesion and oxidised LDL uptake in luteolin-treated human endothelial cells exposed to oxidised LDL. Br. J. Nutr. 97, 447-457.
26. Kao, E.S., Hsu, J.D., Wang, C.J., Yang, S.H., Cheng, S.Y., Lee, H.J., 2009. Polyphenols extracted from Hibiscus sabdariffa L. inhibited lipopolysaccharide-induced inflammation by improving antioxidative conditions and regulating cyclooxygenase-2 expression. Biosci. Biotechnol. Biochem. 73, 385-390.
27. Kita, T., Kume, N., Minami, M., Hayashida, K., Murayama, T., Sano, H., Moriwaki, H., Kataoka, H., Nishi, E., Horiuchi, H., Arai, H., Yokode, M., 2001. Role of oxidised LDL in atherosclerosis. Ann. NY Acad. Sci. 947, 199-206.
28. Kojima, H., Nakatsubo, N., Kawahara, S., Kirino, Y., Nagoshi, H., Hirata, Y., Nagano, T., 1998. Detection and imaging of nitric oxide with novel fluorescent indicators, diaminofluoresceins. Anal. Chem. 70, 2446-2453.
29. Lee, K.W., Kang, N.J., Heo, Y.S., Rogozin, E.A., Pugliese, A., Hwang, M.K., Bowden, G.T., Bode, A.M., Lee, H.J., Dong, Z., 2008. Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine. Cancer Res. 68, 946-955. (Pubitemid 351206774)
30. Li, L., Crockett, E., Wang, D.H., Galligan, J.J., Fink, G.D., Chen, A.F., 2002. Gene transfer of endothelial NO synthase and manganese superoxide dismutase on arterial vascular cell adhesion molecule-1 expression and superoxide production in deoxycorticosterone acetate-salt hypertension. Arterioscler. Thromb. Vasc. Biol. 22, 249-255.
31. Livak, K.J., Schmittgen, T.D., 2001. Analysis of relative gene expression data using realtime quantitative PCR and the 2(-delta delta C(T)) method. Methods 25, 402-408. (Pubitemid 34164012)
32. Meisinger, C., Baumert, J., Khuseyinova, N., Loewel, H., Koenig, W., 2005. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation 112, 651-657. (Pubitemid 41099043)
33. Mossman, T., 1983. Rapid colorimetric assay for cellular growth and survival, application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
34. Nickel, T., Hanssen, H., Sisic, Z., Pfeiler, S., Summo, C., Schmauss, D., Hoster, E., Weis, M., in press. Immunoregulatory effects of the flavonol quercetin in vitro and in vivo. Eur. J. Nutr. PMID: 20652710, doi:10.1007/s00394-010-0125-8.
35. Opie, L.H., Lecour, S., 2007. The red wine hypothesis, from concepts to protective signalling molecules. Eur. Heart J. 28, 1683-1693.
36. Ou, H.C., Chou, F.P., Sheen, H.M., Lin, T.M., Yang, C.H., Huey-Herng Sheu, W., 2006. Resveratrol, a polyphenolic compound in red wine, protects against oxidized LDL-induced cytotoxicity in endothelial cells. Clin. Chim. Acta 364, 196-204.
37. Podrez, E.A., Abu-Soud, H.M., Hazen, S.L., 2000. Myeloperoxidase- generated oxidants and atherosclerosis. Free Radic. Biol. Med. 28, 1717-1725.
38. Radi, R., Peluffo, G., Alvarez, M.N., Navilat, M., Cayota, A., 2001. Unraveling peroxynitrite formation in biological systems. Free Radic. Biol. Med. 30, 463-488.
39. Regnstom, J., Nilsson, J., Moldeus, P., Strom, K., Bavenholm, P., Tornvall, P., Hamsten, A., 1996. Inverse relation between the concentration of low-density-lipoprotein vitamin E and severity of coronary artery disease. Am. J. Clin. Nutr. 63, 377-385.
40. Ross, R., 1999. Atherosclerosis -an inflammatory disease. N. Engl. J. Med. 340, 115-126.
41. Ruiz, E., Padilla, E., Redondo, S., Gordillo-Moscoso, A., Tejerina, T., 2006. Kaempferol inhibits apoptosis in vascular smooth muscle induced by a component of oxidized LDL. Eur. J. Pharmacol. 529, 79-83.
42. Schewe, T., 2002. 15-lipoxygenase-1, a prooxidant enzyme. Biol. Chem. 383, 365-374.
43. Schewe, T., Steffen, Y., Sies, H., 2008. How do dietary flavanols improve vascular function? A position paper. Arch. Biochem. Biophys. 476, 102-106.
44. Sparrow, C.P., Parthasarathy, S., Steinberg, D., 1988. Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification. J. Lipid Res. 29, 745-753.
45. Stangl, V., Lorenz, M., Ludwig, A., Grimbo, N., Guether, C., Sanad, W., Ziemer, S., Martus, P., Baumann, G., Stangl, K., 2005. The flavonoid phloretin suppresses stimulated expression of endothelial adhesion molecules and reduces activation of human platelets. J. Nutr. 135, 172-178. (Pubitemid 40194474)
46. Steffen, Y., Gruber, C., Schewe, T., Sies, H., 2008. Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch. Biochem. Biophys. 469, 209-219.
47. Szmitko, P.E., Verma, S., 2005. Antiatherogenic potential of red wine, clinician update. Am. J. Physiol. Heart Circ. Physiol. 288, H2023-H2030.
48. Tangirala, R.K., Casanada, F., Miller, E., Witztum, J.L., Steinberg, D., Palinski, W., 1995. Effect of the antioxidantN, N′-diphenyl 1,4-phenylenediamine (DPPD) on atherosclerosis in apoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 15, 1625-1630.
49. Tribolo, S., Lodi, F., Connor, C., Suri, S., Wilson, V.G., Taylor, M.A., Needs, P.W., Kroon, P.A., Hughes, D.A., 2008. Comparative effects of quercetin and its predominant human metabolites on adhesion molecule expression in activated human vascular endothelial cells. Atherosclerosis 197, 50-56. (Pubitemid 351273272)
50. Valli, G., Giardina, E.G., 2002. Benefits, adverse effects and drug interactions of herbal therapies with cardiovascular effects. J. Am. Coll. Cardiol. 39, 1083-1095.
51. Van der Vliet, A., Eiserich, J.P., Halliwell, B., Cross, C.E., 1997. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. J. Biol. Chem. 272, 7617-7625.
52. Webb, N.R., 2008. Getting to the core of atherosclerosis. Nat. Med. 14, 1015-1016.
53. Winterbourn, C.C., Vissers, M.C., Kettle, A.J., 2000. Myeloperoxidase. Curr. Opin. Hematol. 7, 53-58.
54. Zhao, H., Kalivendi, S., Zhang, H., Joseph, J., Nithipatikom, K., Vásquez-Vivar, J., Kalyanaraman, B., 2003. Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium, potential implications in intracellular fluorescence detection of superoxide. Free Radic. Biol. Med. 34, 1359-1368.